Stockscreener 앱 받기
15.50
1.04%
0.16
시간 외 거래:
15.57
0.07
+0.45%
Clearpoint Neuro Inc 주식(CLPT)의 최신 뉴스
ClearPoint Neuro (CLPT) Q2 2026 Earnings Call Transcript - AOL.com
(CLPT) Price Dynamics and Execution-Aware Positioning - Stock Traders Daily
ClearPoint Neuro (CLPT): MAK Capital group discloses 7.8% ownership in 13G/A - Stock Titan
ClearPoint Neuro (NASDAQ:CLPT) Downgraded to "Strong Sell" Rating by Wall Street Zen - MarketBeat
Clearpoint Neuro Inc (CLPT) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Analysts Have Lowered Expectations For ClearPoint Neuro, Inc. (NASDAQ:CLPT) After Its Latest Results - 富途牛牛
Clearpoint Neuro Inc (CLPT) Stock News Today - TradingKey
ClearPoint Neuro, Inc. (NASDAQ:CLPT) Just Reported And Analysts Have Been Cutting Their Estimates - simplywall.st
ClearPoint Neuro, Inc. (CLPT) Options Chain - Yahoo! Finance Canada
CLPT Looks 4.6% Overvalued on GF Value™ Ahead of Tuesday Market Drop - GuruFocus
ClearPoint Neuro: Regulatory Momentum Strengthens The Long-Term Investment Case (CLPT) - Seeking Alpha
ClearPoint Neuro Updates Q2 Results and 2026 Outlook - The Globe and Mail
ClearPoint Neuro (CLPT) investors disclose 7.45% beneficial ownership stake - Stock Titan
Lake Street Maintains ClearPoint Neuro(CLPT.US) With Buy Rating, Cuts Target Price to $25 - Moomoo
Stifel cuts Clearpoint Neuro stock price target on guidance cut - Investing.com
Stifel cuts Clearpoint Neuro stock price target on guidance cut By Investing.com - Investing.com South Africa
ClearPoint Neuro, Inc. Q2 2026 Earnings Call Summary - Yahoo Finance
Powell Industries Posts Downbeat Q3 Results, Joins Clearpoint Neuro, Ichor Holdings And Other Big Stocks - Benzinga
CLPT Looks 4.7% Overvalued on GF Value™ - GuruFocus
How Does ClearPoint Neuro Inc (CLPT) Perform in Q2? EPS at -$0.3 - GuruFocus
Earnings call transcript: Clearpoint Neuro Q2 2026 misses estimates as shares fall - Investing.com Canada
ClearPoint Neuro, Inc. (CLPT) Reports Q2 Loss, Misses Revenue Estimates - Yahoo Finance
ClearPoint Neuro Q2 Earnings Call Highlights - Yahoo Finance
Clearpoint Neuro Inc reports results for the quarter ended June 30Earnings Summary - TradingView
ClearPoint Neuro (NASDAQ:CLPT) Issues Quarterly Earnings Results, Misses Estimates By $0.09 EPS - MarketBeat
Transcript : ClearPoint Neuro, Inc., Q2 2026 Earnings Call, Aug 03, 2026 - marketscreener.com
ClearPoint Neuro (CLPT) Stock Falls on Q2 2026 Earnings - Quiver Quantitative
ClearPoint Neuro, Inc. Updates Revenue Guidance for the Year 2026 - marketscreener.com
ClearPoint Neuro Q2 revenue rises 18% but misses estimates - TradingView
ClearPoint Neuro (Nasdaq: CLPT) grows Q2 revenue and updates 2026 outlook - Stock Titan
BRIEF-ClearPoint Neuro Q2 Revenue USD 10.9 Million - tradingview.com
ClearPoint Neuro, Inc. (CLPT) Q2 2026 Earnings - 24/7 Wall St.
ClearPoint Neuro, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com
(CLPT) as a Liquidity Pulse for Institutional Tactics - Stock Traders Daily
Lake Street Maintains ClearPoint Neuro(CLPT.US) With Buy Rating, Maintains Target Price $30 - Moomoo
ClearPoint Neuro Q2 2026 Earnings Call Transcript - MarketBeat
ClearPoint Neuro (CLPT) Gains 2.47% to $14.94 as MedTech Momentum BuildsFactor Valuation - dars.gov.et
Aspen's Parkinson's Cell Therapy Gets FDA RMAT Designation—Not Approval - Stock Titan
Brokers Offer Predictions for CLPT Q2 Earnings - MarketBeat
Clearpoint Neuro Inc (CLPT) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
BlackRock (CLPT holder) discloses 7.1% beneficial stake in ClearPoint Neuro - Stock Titan
CLPT|Clearpoint Neuro Inc|Price:14.412|Chg%:+0.291 - TradingKey
CLPT|Clearpoint Neuro Inc|Price:14.940|Chg%:+0.360 - TradingKey
CLPT|Clearpoint Neuro Inc|Price:15.310|Chg%:+0.370 - tradingkey.com
Clearpoint Neuro Inc (CLPT) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
TradingKey - TradingKey
Clearpoint Neuro Inc (CLPT) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Clearpoint Neuro Inc (CLPT) Balance Sheet - TradingKey
Clearpoint Neuro Inc (CLPT) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
CLPT|Clearpoint Neuro Inc|Price:14.120|Chg%:-0.370 - TradingKey
(CLPT) Risk Channels and Responsive Allocation - Stock Traders Daily
CLPT Q1 2026 Earnings: EPS Misses Estimates, Stock Still RisesRevenue Guidance Range - dars.gov.et
ClearPoint Neuro to announce Q2 2026 results on August 3 - scanx.trade
Articles from ClearPoint Neuro, Inc. - FinancialContent
ClearPoint Neuro to Announce Second Quarter 2026 Results August 3, 2026 - ACCESS Newswire
ClearPoint Neuro Q2 review starts Aug. 3 at 4:30 p.m. ET - Stock Titan
ClearPoint Neuro Inc. (CLPT) Q1 2026 Earnings: EPS Misses Estimates, Stock Declines Over 3%Margin Expansion Trends - dars.gov.et
EpilepsyGTx Taps ClearPoint Neuro for EPY201 Clinical Trial Delivery - Contract Pharma
ClearPoint Neuro Slips Over 3% as Shares Test Key Support LevelsWave Equality - dars.gov.et
Why I've (Reluctantly) Sold My ClearPoint Neuro Position (NASDAQ:CLPT) - Seeking Alpha
2.43%
자본화:
|
볼륨(24시간):